CIK 0000883984
- Large accelerated filer
ICU MEDICAL INC/DE
Sign in to watch- Ticker
- ICUI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330022692
- Phone
- +1 949-366-2183
- Business address
- 951 CALLE AMANECER, SAN CLEMENTE, CA, 92763-6212
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,859,904
- in 4 filings, $3.5M under 10b5-1 plans
Net −$3,859,904. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-27 | Voigtlander Christian B. Chief Operating Officer | Sale | −1,430 | $158.00 | $226K | 0 |
| 2024-11-27 | Greenberg David C. Director | Sale | −972 | $158.11 | $154K | 5,037 |
| 2024-11-26 | Voigtlander Christian B. Chief Operating Officer | Sale | −7,513 | $159.09 | $1.2M | 206 |
| 2024-11-26 | Voigtlander Christian B. Chief Operating Officer | Sale | −206 | $160.09 | $33K | 0 |
| 2024-11-25 | Voigtlander Christian B. Chief Operating Officer | Sale | −1,962 | $169.08 | $332K | 0 |
| 2024-11-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −4,228 | $170.75 | $722K | 112,365 |
| 2024-11-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −4,147 | $171.91 | $713K | 108,218 |
| 2024-11-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −2,386 | $172.76 | $412K | 105,832 |
| 2024-11-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −1,239 | $173.60 | $215K | 104,593 |
| 2024-10-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −4,156 | $177.50 | $738K | 112,437 |
| 2024-10-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,681 | $178.49 | $657K | 108,756 |
| 2024-10-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,375 | $179.16 | $605K | 105,381 |
| 2024-10-01 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −788 | $180.48 | $142K | 104,593 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,755 | $162.69 | $611K | 104,593 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −4,440 | $163.59 | $726K | 104,593 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,805 | $164.07 | $624K | 104,593 |
| 2024-08-30 | Woolson Daniel VP, GM-Infusion Capital | Sale | −2,502 | $163.22 | $408K | 13,107 |
| 2024-08-16 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −12,000 | $156.04 | $1.9M | 104,593 |
| 2024-08-08 | Sanzone Virginia Ruth VP, General Counsel | Sale 10b5-1 | −2,050 | $144.11 | $295K | 4,482 |
| 2024-05-30 | Voigtlander Christian B. Chief Operating Officer | Sale | −10,507 | $103.85 | $1.1M | 2,032 |
Page 3 of 15 · 282 trades